Axcan Pharma Inc.

Axcan Pharma Inc. (Axcan) is a privately held specialty pharmaceutical company engaged in development and commercialization of drugs for the treatment of gastrointestinal ailments. It has more than 40 products and dosages in the market for the treatment of inflammatory bowel disease, cholestatic liver diseases, irritable bowel syndrome, and complications related to pancreatic insufficiency. It also conducts research and development of advanced stage products acquired from third parties. The company has its operations in North America and Europe with its headquarters located in Quebec, Canada.

In February 2008, Axcan Pharma, Inc. was acquired by an affiliate of TPG capital, a global buyout group of a leading private investment firm.

Street: 
597 Laurier Boulevard
City: 
Mont Saint Hilaire
Postcode: 
J3H 6C4
Federal State : 
Canada
WebSite: 
www.axcan.com
Fax: 
1-450-4649979

Company Index Score

Current Index Score Historical Index Score
  • Axcan Pharma Inc. currently scores 50 % in the index.
  • Axcan Pharma Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Axcan Pharma Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets